 LAVAL, Québec, Sept. 22, 2021 GLOBE NEWSWIRE -- Acasti Pharma Inc. Acasti or the Company Nasdaq: ACST and TSX-V: ACST, today provided a business update and announced that the Nasdaq Stock Market Nasdaq has confirmed to Acasti that the Company has regained compliance with Nasdaqs minimum bid price requirement. 